New Key Statistics Module, Z-Score and F-Score
NAS:AMYT Key Ratios
| Market Cap $ M | 942.77 |
| Enterprise Value $ M | 1,072.31 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 26.11 |
| Price/Book | 2.90 |
| Price/Sales | 3.98 |
| Price/Free Cash Flow | 10.04 |
| Price/Owner Earnings | 7.12 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 243.00 |
| EPS (TTM) $ | -0.30 |
| Beneish M-Score | -3.7 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 40.96 |
| EV-to-EBITDA | 12.14 |
| PEG | -- |
| Shares Outstanding M | 64.13 |
| Net Margin (%) | -0.32 |
| Operating Margin % | -18.50 |
| Pre-tax Margin (%) | -0.56 |
| Quick Ratio | 0.94 |
| Current Ratio | 1.57 |
| ROA % (ttm) | -0.10 |
| ROE % (ttm) | -0.24 |
| ROIC % (ttm) | -4.71 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.44 |
AMYT Number of Guru Trades
AMYT Volume of Guru Trades
Gurus Latest Trades with NAS:AMYT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AMYT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Amryt Pharma PLC Insider Transactions
No Available Data
News about NAS:AMYT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers